Lista de obras - Fabio Puglisi - Dominio Público Uruguay

"To Anticipate": Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers

scientific article published on 17 July 2020

A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer

artículo científico publicado en 2016

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

artículo científico publicado en 2018

A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity

artículo científico publicado en 2020

A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer

artículo científico publicado en 2010

Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers

artículo científico publicado en 2012

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

artículo científico publicado en 2016

Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM)

article

Adjuvant ovarian function suppression and cognitive function in women with breast cancer.

artículo científico publicado en 2016

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

article

Androgen receptor in estrogen receptor positive breast cancer: Beyond expression

artículo científico publicado en 2017

Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype

artículo científico publicado en 2018

Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells

scientific article published on 01 September 2007

Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients

artículo científico

Atezolizumab for the treatment of Breast Cancer.

artículo científico publicado en 2018

B-cell lymphoma presenting as acute pancreatitis

artículo científico publicado en 2011

BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy

scientific article published on 04 December 2018

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress

artículo científico publicado en 2016

Balance between Cell Division and Cell Death as Predictor of Survival in Patients with Non-Small-Cell Lung Cancer

Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications

artículo científico publicado en 2005

Bevacizumab in older patients with advanced colorectal or breast cancer.

artículo científico

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, rando

artículo científico publicado en 2014

Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole

artículo científico publicado en 2014

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients' heart?

artículo científico publicado en 2014

Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in Italy.

artículo científico publicado en 2016

Central nervous system involvement in breast cancer patients: Is the therapeutic landscape changing too slowly?

artículo científico publicado en 2016

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

artículo científico publicado en 2017

Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis.

artículo científico publicado en 2016

Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?

artículo científico publicado en 2019

Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study

artículo científico publicado en 2020

Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study

artículo científico publicado en 2020

Cognitive functions and elderly cancer patients receiving anticancer treatment: A prospective study

artículo científico publicado en 2008

Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas

article

Combined yolk sac tumor and adenocarcinoma in a gastric stump: molecular evidence of clonality

artículo científico publicado en 1999

Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy.

artículo científico publicado en 2018

Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey

artículo científico publicado en 2018

Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly.

artículo científico publicado en 2007

Current challenges in HER2-positive breast cancer.

artículo científico publicado en 2015

D-dimer and venous thromboembolism

artículo científico publicado en 2004

Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme

artículo científico publicado en 2018

Determinants of Last-line Treatment in Metastatic Breast Cancer

artículo científico

Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era.

artículo científico publicado en 2009

Diagnostic accuracy of perforated compression grid approach for mammographically guided core needle biopsy of breast lesions

artículo científico publicado en 1999

Do platinum salts fit all triple negative breast cancers?

artículo científico publicado en 2016

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

artículo científico publicado en 2016

Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report

artículo científico publicado en 2006

Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients.

artículo científico publicado en 2008

Efficacy and safety of eribulin in taxane-refractory patients in the 'real world'.

artículo científico publicado en 2017

Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity

artículo científico publicado en 2019

Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence

artículo científico publicado en 2015

Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells.

artículo científico publicado en 2015

Eribulin in the treatment of advanced breast cancer: real-world scenario from 39 Italian centers - ESEMPiO study

article

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials

artículo científico publicado en 2017

Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients

artículo científico publicado en 2013

Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy

artículo científico publicado en 2012

Expression of Dicer and Drosha in triple-negative breast cancer.

artículo científico publicado en 2012

Expression of periostin in human breast cancer

artículo científico publicado en 2007

Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma.

artículo científico publicado en 2013

Factors affecting patient's perception of anticancer treatments side-effects: an observational study

artículo científico publicado en 2013

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

artículo científico publicado en 2012

Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.

artículo científico publicado en 2016

First-line chemotherapy with or without biologic agents for metastatic breast cancer.

artículo científico publicado en 2010

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

artículo científico publicado en 2015

Follow-up of patients with early breast cancer: is it time to rewrite the story?

artículo científico publicado en 2014

From the podium to the patient: bringing the 2008 ASCO meeting to the clinic.

artículo científico publicado en 2008

Galectin-3 expression in non-small cell lung carcinoma

Gene expression profiling in breast cancer: a clinical perspective.

artículo científico

HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma

artículo científico publicado en 2022

HEX expression and localization in normal mammary gland and breast carcinoma

scientific journal article

Hepatitis B and cancer: A practical guide for the oncologist

artículo científico publicado en 2016

Highlights from the 42nd annual meeting of the American Society of Clinical Oncology Atlanta, GA, USA, 2-6 June 2006.

artículo científico publicado en 2006

Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines.

artículo científico publicado en 2011

Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology

artículo científico publicado en 2008

Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results.

artículo científico publicado en 2017

Hype or hope? The strange case of platinum salts' renaissance in breast cancer

artículo científico publicado en 2019

Image-guided core breast biopsy: a suitable method for preoperative biological characterization of small (pT1) breast carcinomas

scientific article published on 01 November 1998

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer.

artículo científico publicado en 2017

Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma.

artículo científico publicado en 1998

Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).

artículo científico publicado en 2013

In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis

artículo científico publicado en 2016

Information to cancer patients: a questionnaire survey in three different geographical areas in Italy

artículo científico publicado en 2008

Lack of correlation between immunohistochemical expression of E2F-1, thymidylate synthase expression and clinical response to 5-fluorouracil in advanced colorectal cancer

artículo científico publicado en 2004

Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker

scientific article published on 24 August 2019

Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas

scientific article published on 01 September 1996

Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation

scientific article published on 01 January 2010

Looking for predictive markers in breast cancer

scientific article published on 29 December 2014

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.

artículo científico publicado en 2016

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis

artículo científico publicado en 2017

MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme

artículo científico publicado en 2018

MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index.

artículo científico publicado en 2015

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

artículo científico publicado en 2011

Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase?

artículo científico

Markers of the uPA system and common prognostic factors in breast cancer

artículo científico publicado en 2007

Measures of outcome in metastatic breast cancer: insights from a real-world scenario

artículo científico publicado en 2014

Microscopic thymoma and myasthenia gravis.

artículo científico publicado en 1995

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside

artículo científico publicado en 2019

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

artículo científico publicado en 2006

Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients.

artículo científico publicado en 2015

Oncological care organisation during COVID-19 outbreak

artículo científico publicado en 2020

One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis.

artículo científico publicado en 2013

Overcoming treatment resistance in HER2-positive breast cancer: potential strategies.

artículo científico

Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options

artículo científico publicado en 2020

PTEN and Egr-1 expression in thyroid proliferative lesions.

artículo científico publicado en 2004

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

artículo científico publicado en 2018

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

artículo científico publicado en 2015

Pattern of metastasis and outcome in patients with breast cancer.

artículo científico publicado en 2015

Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study.

artículo científico publicado en 2015

Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study

artículo científico publicado en 2017

Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.

artículo científico publicado en 2008

Pertuzumab and breast cancer: another piece in the anti-HER2 puzzle

artículo científico publicado en 2017

Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.

artículo científico publicado en 2009

Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer

artículo científico publicado en 2007

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer

artículo científico publicado en 2010

Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole. ⬇️

artículo científico publicado en 2012

Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors

artículo científico publicado en 2019

Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation

scientific article published on 30 October 2018

Predictors of axillary lymph node metastases in patients with T1 breast carcinoma

scientific article published on 01 April 1998

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

scientific article published on 01 May 2019

Preoperative Carboplatin–Paclitaxel–Bevacizumab in Triple-Negative Breast Cancer: Final Results of the Phase II Ca.Pa.Be Study

artículo científico publicado en 2015

Primary therapy in breast cancer: what have we learned from landmark trials?

artículo científico publicado en 2013

Prognostic evaluation in palliative care: final results from a prospective cohort study

scientific article published on 18 September 2018

Proteomic evaluation of core biopsy specimens from breast lesions

artículo científico publicado en 2004

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example.

artículo científico publicado en 2016

Reply to the letter "Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association".

artículo científico publicado en 2018

Risk factors and survival outcomes in patients with brain metastases from breast cancer

artículo científico publicado en 2013

Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover study

artículo científico publicado en 2014

Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer

scientific article published on 24 June 2019

Role of mammography, ultrasound and large core biopsy in the diagnostic evaluation of papillary breast lesions

artículo científico publicado en 2003

Role of pre-surgical breast MRI in the management of invasive breast carcinoma

artículo científico publicado en 2007

Second-line single-agent chemotherapy in human epidermal growth factor receptor 2-negative metastatic breast cancer: A systematic review

artículo científico publicado en 2015

Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001).

artículo científico publicado en 2004

Shrinking the tumor, shrinking the patient sample size: the early disclosure dilemma

artículo científico publicado en 2005

Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.

artículo científico

Sonographic criteria for differentiation of benign and malignant solid breast lesions: size is of value

artículo científico publicado en 2006

Stereotactic vacuum-assisted breast biopsy: results, follow-up and correlation with radiological suspicion

scientific article published on 19 March 2007

TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung

scientific article published on 01 February 1998

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

artículo científico publicado en 2018

Tamoxifen-induced total alopecia

artículo científico publicado en 2001

Taxane-induced nail changes: incidence, clinical presentation and outcome.

artículo científico publicado en 2003

The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer

scientific article published on 18 May 2019

The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients

artículo científico publicado en 2019

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.

artículo científico publicado en 2016

Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer

artículo científico publicado en 2008

Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer

artículo científico publicado en 2008

Topoisomerase IIalpha and APE/ref-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer

artículo científico publicado en 2004

Translational and clinical research highlights from the 38th San Antonio Breast Cancer Symposium

artículo científico publicado en 2016

Trastuzumab and breast cancer. Are we just beyond the prologue of a fascinating story?

artículo científico publicado en 2005

Treatment of HER2-positive breast cancer: current status and future perspectives.

artículo científico publicado en 2011

Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?

artículo científico publicado en 2015

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.

artículo científico publicado en 2017

Tumour-infiltrating lymphocytes, programmed death ligand 1 and cyclooxygenase-2 expression in skin melanoma of elderly patients: clinicopathological correlations

artículo científico publicado en 2018

Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study : Complementary and alternative medicine in oncology

scientific article published on 24 July 2018

Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM).

artículo científico publicado en 2014

What does similarity mean in clinical trials?

artículo científico publicado en 2009

Lista de obras de Fabio Puglisi

"To Anticipate": Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers

A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity

A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer

Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM)

Adjuvant ovarian function suppression and cognitive function in women with breast cancer.

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

Androgen receptor in estrogen receptor positive breast cancer: Beyond expression

Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype

Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells

Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients

Atezolizumab for the treatment of Breast Cancer.

B-cell lymphoma presenting as acute pancreatitis

BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress

Balance between Cell Division and Cell Death as Predictor of Survival in Patients with Non-Small-Cell Lung Cancer

Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications

Bevacizumab in older patients with advanced colorectal or breast cancer.

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, rando

Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients' heart?

Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in Italy.

Central nervous system involvement in breast cancer patients: Is the therapeutic landscape changing too slowly?

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis.

Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?

Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study

Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study

Cognitive functions and elderly cancer patients receiving anticancer treatment: A prospective study

Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas

Combined yolk sac tumor and adenocarcinoma in a gastric stump: molecular evidence of clonality

Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy.

Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey

Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly.

Current challenges in HER2-positive breast cancer.

D-dimer and venous thromboembolism

Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme

Determinants of Last-line Treatment in Metastatic Breast Cancer

Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era.

Diagnostic accuracy of perforated compression grid approach for mammographically guided core needle biopsy of breast lesions

Do platinum salts fit all triple negative breast cancers?

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report

Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients.

Efficacy and safety of eribulin in taxane-refractory patients in the 'real world'.

Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity

Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence

Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells.

Eribulin in the treatment of advanced breast cancer: real-world scenario from 39 Italian centers - ESEMPiO study

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials

Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients

Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy

Expression of Dicer and Drosha in triple-negative breast cancer.

Expression of periostin in human breast cancer

Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma.

Factors affecting patient's perception of anticancer treatments side-effects: an observational study

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.

First-line chemotherapy with or without biologic agents for metastatic breast cancer.

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

Follow-up of patients with early breast cancer: is it time to rewrite the story?

From the podium to the patient: bringing the 2008 ASCO meeting to the clinic.

Galectin-3 expression in non-small cell lung carcinoma

Gene expression profiling in breast cancer: a clinical perspective.

HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma

HEX expression and localization in normal mammary gland and breast carcinoma

Hepatitis B and cancer: A practical guide for the oncologist

Highlights from the 42nd annual meeting of the American Society of Clinical Oncology Atlanta, GA, USA, 2-6 June 2006.

Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines.

Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology

Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results.

Hype or hope? The strange case of platinum salts' renaissance in breast cancer

Image-guided core breast biopsy: a suitable method for preoperative biological characterization of small (pT1) breast carcinomas

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer.

Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma.

Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).